Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 09:00 ET | Source: Optigo Biotherapeutics Inc.

Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies

Dr. Andreas Wallnöfer joins the board of Optigo Biotherapeutics – the ophthalmology company pioneering next-gen treatments for retinal diseases.
May 06, 2025 20:00 ET | Source: Optigo Biotherapeutics Inc.

Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference

Optigo Bio Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at ARVO 2025